Abstract
Antacids show gastroprotective action against various irritants in experimental animals and enhance the healing of chronic gastroduodenal ulcers in humans but the mechanisms of these effects are unknown. The present study was designed to determine whether prostaglandin (PG) and epidermal growth factor (EGF), which also have protective and antiulcer properties, contribute to the action of antacids on rat's stomach. It was found that Maalox 70 and its active component, Al(OH)3, enhance significantly the healing of chronic gastric and duodenal ulcers observed during 7 and 14 days after their induction. Pretreatment with indomethacin caused a significant prolongation of ulcer healing, and this was accompanied by a significant reduction in PG and EGF formation, suggesting that both factors may be involved in ulcer healing. Maalox and Al(OH)3 failed to prevent the suppression of PG by indomethacin but were equally effective in ulcer healing in rats without and with indomethacin administration, suggesting that endogenous PG may not play any important role in the healing process by these drugs. Removal of salivary glands, the major source of EGF, also prolonged ulcer healing but, again, Maalox was as effective in ulcer healing as in rats with intact salivary glands. Our findings that Maalox at pH above 3.0 binds significant amounts of EGF, enhances the binding of EGF to the ulcer area, and stimulates mucosal growth, suggest that EGF may be involved in ulcer healing; however, because antacids are also effective after sialoadenectomy, EGF does not seem to be the major factor in ulcer healing by these drugs.
Similar content being viewed by others
References
Engler H, Szelenyi I: Tierexperimentelle underschungen zur antiulzerogenen wirung vershciedener antazida. Therapiewoche 30:5743–5746, 1980
Szelenyi I, Postius S, Engler H: Evidence for a functional cytoprotective effect produced by antacids in the rat stomach. Eur J Pharmacol 88:403–406, 1983
Tarnawski A, Hollander D, Cummings D, Krause WJ, Gergely H, Zipser RD: Are antacids acid neutralisers only? Histologic, ultrastructural and functional changes in normal gastric mucosa induced by antacids. Gastroenterology 86:1276–1281, 1984
Domschke W, Hagel J, Puppin H, Kaduk B: Antacids and gastric mucosal protection. Scand J Gastroenterol 21(suppl 125):144–149, 1986
Tarnawski A, Hollander D, Gergely H, Stachura J: Comparison of antacid, sucralfate, cimetidine and ranitidine in protection of the gastric mucosa against ethanol injury. Am J Med 79(suppl 26):19–23, 1985
Hollander D, Tarnawski A, Gergely H: Protection against alcohol-induced gastric mucosal injury by aluminium/containing compounds-sucralfate, antacids and aluminum sulfate. Scand J Gastroenterol 21(suppl 125):151–153, 1986
Priebe JH, Skillman JJ, Bushnell LS, Long PC, Silen W: Antacid versus cimetidine in preventing acute gastrointestinal bleeding: A randomized trial in 75 critically ill patients. N Engl J Med 302:426–430, 1980
Peterson WL, Sturdevant AL, Frankl HD, Richardson ChT, Isenberg JI, Elashoff JD, Stones JQ, Gross RA, McCallum RW, Fordtran JS: Healing of duodenal ulcer with an antacid regimen. N Engl J Med 297:341–345, 1977
Ippoliti AF, Sturdevant RAL, Isenberg JI, et al: Cimetidine versus intensive antacid therapy for duodenal ulcer. A multicenter trial. Gastroenterology 74:393–395, 1978
Fedeli G, Anti M, Rapaccini GL, De Vitis I, Butti A, Civelo IM: A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer. Dig Dis Sci 24:758–762, 1979
Lam SK, Lam KC, Lai CL, et al: Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study. Gastroenterology 76:315–322, 1979
Berstad A, Rydning A, Aaland E, Kolstad B, Frislid K, Asseth J: Controlled clinical trial of duodenal ulcer healing with antacid tablets. Scand J Gastroenterol 17:953–959, 1982
Kumar N, Vij JC, Karol A, Anand BS: Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer. Gut 25:1199, 1984
Faizallah R, De Haan HA, Krasner N, Walker RJ, Morris AI, Calam MJ, Budgett DA: Is there a place in the United Kingdom for intensive antacid treatment for chronic peptic ulceration? Br Med J 289:869–871, 1984
Laurisen K, Bytzer P, Hansen J, Bekker C, Rask-Madsen J: Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. A double-blind controlled trial. Scand J Gastroenterol 20:123–138, 1985
Bianchi-Porro G, Parente F, Lazzaroni M, Baroni S, Panza E: Medium-dose antacids versus cimetidine in the short-term treatment of duodenal ulcer. J Clin Gastroenterol 8:141–154, 1986
Bianchi Porro G, Lazzaroni M, Pace F, Petrillo M: Long-term low dose antacid versus cimetidine therapy in the treatment of duodenal ulcer recurrence. Scand J Gastroenterol 21:1144–1146, 1986
Rynding A, Weberg R, Lange O, Berstad A: Healing of benign gastric ulcer with low-dose antacids and fiber diet. Gastroenterology 91:56–61, 1986
Isenberg JI, Peterson WI, Elashoff JD, et al: Healing of benign gastric ulcer with low-dose antacid and cimetidine. A double-blind, randomized, placebo-controlled trial. N Engl J Med 308:1319–1324, 1983
Pace F, Broker HJ, Caspary W, Feurle G, Fimmel CJ, Hackenberg K, Hammer B, Holtermuller KH, Hotz J: Therapy of stomach ulcer with low-dose antacid gel and cimetidine. A multicenter double-blind study. Dtsch Med Wochenschr 11:183–187, 1985
Berstad A, Weberg R: Antacids for peptic ulcer: Do we have anything better? Scand J Gastroenterol 21:144–147, 1986
Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 77:433–443, 1979
Konturek SJ, Radecki T, Brzozowski T, Piastucki I, Dembinski A, Dembinska-Kiec A, Zmuda A, Gryglewski R, Gregory H: Gastric cytoprotection by epidermal growth factor. Role of endoengous prostaglandins and DNA synthesis. Gastroenterology 81:438–443, 1981
Skov Olsen P, Poulssen SS, Kirkegaard P, Nexo E: Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology 87:103–108, 1984
Skov Olsen P, Poulsen SS, Therkelsen K, Nexo E: Effect of sialoadenectomy and synthetic human urogastrone on healing of chronic gastric ulcers in rats. Gut 27:1443–1449, 1986
Skov Olsen P, Poulsen SS, Therkelsen K, Nexo E: Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcers in rats. Gastroenterology 90:911–917, 1986
Konturek SJ, Stachura J, Radecki T, Drozdowicz D, Brzozowski T: Cytoprotective and ulcer healing properties of prostaglandin E2in rats. Digestion 38:103–113, 1987
Konturek SJ, Dembinski A, Warzecha Z, Bielanski W, Brzozowski T, Drozdowicz D: Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats. Gut 29:894–902, 1986
Okabe S, Pfeiffer CJ, Roth JLA: A method for experimental, penetrating gastric and duodenal ulcers in rats. Am J Dig Dis 16:277–284, 1971
Debminski A, Gregory H, Konturek SJ, Polanski M. Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. J Physiol (London) 325:35–42, 1982
Konturek SJ, Radecki T, Brzozowski T, Drozdowicz D, Piastucki I, Muramatsu M, Tanaka M, Aihara H: Antiulcer and gastroprotective effects of solon, a synthetic flavonoid derivative of sophoradain. Role of endogenous prostaglandins. Eur J Pharmacol 125:185–192, 1986
Konturek SJ, Brzozowski T, Dembinski A, Warzecha Z, Konturek PK, Yanaihara N: Interaction of growth hormone-releasing factor and somatostatin on ulcer healing and mucosal growth in rats. Role of gastrin and epidermal growth factor. Digestion 41:121–128, 1988
Vantrappen G, Rutgeerts P, Broekart L, Janssens J: Randomized open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer. Gut 21:329–353, 1981
Kang JY, Piper DW: Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Digestion 23:73–79, 1982
Hamilton I, Worsley BW, O'Connor HJ, Axon ATR: The effects of tripotassium dicitratobismuthate tablets or cimetidine in the treatment of duodenal ulcer. Gut 24:1148–1151, 1983
Clain JE, Malagelada JR, Chadwick VS: Binding propertiesin vitro of antacids for conjugated bile acids. Gastroenterology 73:556–559, 1977
Reimann HJ, Schmidt U, Wendt P, Dorsch W, von Sanden H, von der Ohe M, Lewin J, Ultsch B: Die Wirkung von Antazida auf den Gehalt von Gewebshistamin und Prostaglandinen (PGE2) in der Magenmukoza. Fortschr Med 102:47–50, 1984
Preclik G, Stange EF, Gerber K, Fetzer G, Harn H, Ditchuneit H: Stimulation of mucosal prostaglandin synthesis in human stomach and duodenum by antacid treatment. Gut 30:148, 1989
Hawkey CJ, Walt RP: Prostaglandins for peptic ulcer promise unfulfilled. Lancet 2:1084–1086, 1986
Wang JY, Yamaski S, Takeuchi K, Okabe S: Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology 96:393–402, 1989
Yamamoto O, Okada Y, Okabe S: Effects of a proton pump inhibitor omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Dig Dis Sci 29:394–401, 1984
Konturek SJ, Dembinski A, Warzecha Z, Brzozowski T, Gregory H: Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 94:1300–1307, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Konturek, S.J., Brzozowski, T., Drozdowicz, D. et al. Healing of chronic gastroduodenal ulcerations by antacids. Digest Dis Sci 35, 1121–1129 (1990). https://doi.org/10.1007/BF01537585
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01537585